China's Best One-Stop Medical Equipment Provider
About

Tissue Regenix Group is an international medical technology company based in Leeds, England, specializing in regenerative medicine. The company focuses on developing innovative products using its proprietary technologies: dCELL®, which addresses soft tissue needs, and BioRinse™, which provides sterile bone allografts. Their flagship product, DermaPure®, is a decellularized dermal allograft designed to support better clinical outcomes in soft tissue repair. The company’s technology features a patented decellularization process that effectively removes DNA and cellular material from donor tissues, minimizing the risk of rejection while preserving the tissue's natural structure. Tissue Regenix aims to improve patient care across various surgical fields, including BioSurgery, Orthopaedics, Dental, General Surgery, Plastic Surgery, Urology/Gynaecology, Ophthalmology, and Cardiac surgery. They distribute their products through strategic partnerships and direct sales globally, positioning themselves as leaders in regenerative medicine innovation.

Technologies
Outlook Microsoft Office 365 Microsoft Azure Hosting Google Maps (Non Paid Users) ASP.NET Google Maps Bootstrap Framework Google Tag Manager Mobile Friendly Google Analytics Google Font API Remote
Keywords
development manufacture commercialisation of medical devices regenerative medicine biotech orthobiologics medical equipment manufacturing medical equipment and supplies manufacturing biological scaffolds osteogenic properties clinical tissue regeneration regenerative surgical tools tissue engineering platform biorinse platform clinical evidence regenerative solutions tissue scaffolding growth factors medical technology plastic surgery dental regenerative products regenerative products biological tissue scaffolds patient care orthopaedics cell therapy tissue repair technology tissue regeneration medical devices birth tissue products
Company Information
  • Employees 82
  • Founded 2006
  • Annual Revenue $28646000
  • Total Funding $73370159
Location

Unit 6 Astley Way, Swillington, England, United Kingdom, LS26 8XT

Related Companies
Companies in the same industry